It's quite funny actually, I had stopped thinking about 2RT for a long time. iTrack Advance was moving so fast that 2RT no longer even seemed necessary. However the LCD proposal caused me to go back and research it again, which definitely reminded me of the huge potential this has (and why I originally invested, which was due to 2RT). The partnership has taken a bit of time, but that's to be expected when you're talking about a deal valued in the hundreds of millions of dollars.
If 2RT does get a partnership then we're on. Everything is already planned and ready to go. There will be no diddle daddling, this will move fast. I have no doubt it'll perform spectacularly well in clinical trials, the LEAD trial was promising but even from an intuitive sense the technology behind it makes a lot of sense. Very easy to understand why this would be an effective treatment for AMD, and potentially many other eye diseases.
Nova Eye Medical (EYE) Discussion, page-1345
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
0.005(2.63%) |
Mkt cap ! $44.66M | |||
| Open | High | Low | Value | Volume |
| 19.0¢ | 19.5¢ | 19.0¢ | $17.33K | 91.24K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 45000 | 18.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.5¢ | 29999 | 1 |
View Market Depth
| Last trade - 16.10pm 17/09/2024 (20 minute delay) ? |
| EYE (ASX) Chart |